Open Pharma
Browse
- No file added yet -

April 2021 virtual Open Pharma roundtable meeting report

Download (818.13 kB)
Version 2 2021-06-08, 15:20
Version 1 2021-06-08, 14:26
online resource
posted on 2021-06-08, 15:20 authored by Francesca OunsworthFrancesca Ounsworth, Caitlin Edgell, Tim KoderTim Koder, Tanya Stezhka, Sarah Hewitt, Zoe WattsZoe Watts, Paul Farrow, Chris Winchester

On 23 April 2021, Members, Supporters and Advisers of Open Pharma and a group of publishing company representatives met for a virtual roundtable meeting to:

1. identify the benefits and risks to pharma, publishers and wider stakeholders in healthcare of open access (OA) agreements between pharma and publishers

2. agree whether there is a role for Open Pharma in future discussions on this topic.

History

Usage metrics

    Open Pharma

    Categories

    Keywords

    Open ScienceTransparencyDiscoverabilityAccountabilityAccessibilityOpen AccessOpen Access AgreementsTransformative AgreementsScience PolicyHealth CarePharmaceutical Sciences

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC